Skip to main content
. 2011 Nov 29;34(3):738–752. doi: 10.1002/hbm.21471

Figure 2.

Figure 2

Areas of increased activity associated with placebo analgesia in the expectation stage 1 and during noxious stimulation stage 2. Areas of decreased activity associated with placebo analgesia in stage 2 are also shown. ALE maps were computed using GingerALE 2.0.4 at an FDR‐corrected threshold of P < 0.05, with a minimum cluster size of K > 50 mm3 and visualized using MRIcron. They were projected onto a 3D rendering model of the brain.